Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMHQ2U8)

Drug Name

IMC-F106C Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1/2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Tumor expressed melanoma antigen (PRAME)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
IMA 203	DMD9U5Q	Hematologic tumour	2B33.Y	Phase 1	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Tumor expressed melanoma antigen (PRAME)	TTPH7T0	PRAME_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT04262466) Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Immunocore.
3	Clinical pipeline report, company report or official report of Immatics.